Standout Papers

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Pati... 2010 2026 2015 2020 395
  1. Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse (2010)
    Éric Pujade-Lauraine, Uwe Wagner et al. Journal of Clinical Oncology

Immediate Impact

1 from Science/Nature 77 standout
Sub-graph 1 of 19

Citing Papers

Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer
2024 Standout
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2023 Standout
1 intermediate paper

Works of Birgit Volgger being referenced

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
2010 Standout
Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix
2008

Author Peers

Author Last Decade Papers Cites
Birgit Volgger 359 204 250 17 620
Catherine N. Correa 313 146 232 17 688
W. Schroeder 459 281 154 17 632
Albert Steren 330 177 254 21 708
Elly Brockbank 404 187 190 22 671
Decker Dg 370 151 136 22 590
George Vlahos 237 124 267 22 651
Maurie Markman 492 350 179 27 668
Ross Barner 242 105 140 14 538
Malkasian Gd 463 202 116 32 687
D. Paraïso 365 200 247 33 631

All Works

Loading papers...

Rankless by CCL
2026